APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gonadotropin-releasing Hormone Antagonists

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gonadotropin-releasing Hormone Antagonists Market Analysis and Forecast 2026-2032

Report ID 17399612022 January 2026190 pages

Choose your research edition.

Industry ResearchGonadotropin-releasing Hormone Antagonists Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Gonadotropin-releasing Hormone Antagonists Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Gonadotropin-releasing Hormone Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gonadotropin-releasing Hormone Antagonists Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Gonadotropin-releasing Hormone Antagonists Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Gonadotropin-releasing Hormone Antagonists market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gonadotropin-releasing Hormone Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gonadotropin-releasing Hormone Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gonadotropin-releasing Hormone Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gonadotropin-releasing Hormone Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gonadotropin-releasing Hormone Antagonists include Ferring Pharmaceuticals, Kissei, Myovant Sciences, Veru Inc, AstraZeneca, AbbVie, Astellas, Jiangsu Hengrui Medicine Co and Takeda, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gonadotropin-releasing Hormone Antagonists, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gonadotropin-releasing Hormone Antagonists, also provides the sales of main regions and countries. Of the upcoming market potential for Gonadotropin-releasing Hormone Antagonists, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gonadotropin-releasing Hormone Antagonists sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gonadotropin-releasing Hormone Antagonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gonadotropin-releasing Hormone Antagonists sales, projected growth trends, production technology, application and end-user industry.

Gonadotropin-releasing Hormone Antagonists Segment by Company

Ferring Pharmaceuticals

Kissei

Myovant Sciences

Veru Inc

AstraZeneca

AbbVie

Astellas

Jiangsu Hengrui Medicine Co

Takeda

Gonadotropin-releasing Hormone Antagonists Segment by Type

Peptides

Small Molecules

Gonadotropin-releasing Hormone Antagonists Segment by Application

Endometriosis

Uterine Fibroids

Prostate Cancer

Female Infertility

Others

Gonadotropin-releasing Hormone Antagonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gonadotropin-releasing Hormone Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gonadotropin-releasing Hormone Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gonadotropin-releasing Hormone Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gonadotropin-releasing Hormone Antagonists in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gonadotropin-releasing Hormone Antagonists manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gonadotropin-releasing Hormone Antagonists sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gonadotropin-releasing Hormone Antagonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Peptides Major Manufacturers Table 3. Small Molecules Major Manufacturers Table 4. Global Gonadotropin-releasing Hormone Antagonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Endometriosis Major Manufacturers Table 6. Uterine Fibroids Major Manufacturers Table 7. Prostate Cancer Major Manufacturers Table 8. Female Infertility Major Manufacturers Table 9. Others Major Manufacturers Table 10. Gonadotropin-releasing Hormone Antagonists Industry Trends Table 11. Gonadotropin-releasing Hormone Antagonists Industry Drivers Table 12. Gonadotropin-releasing Hormone Antagonists Industry Opportunities and Challenges Table 13. Gonadotropin-releasing Hormone Antagonists Industry Restraints Table 14. Global Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2021-2026) Table 18. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2027-2032) Table 19. Global Gonadotropin-releasing Hormone Antagonists Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 20. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2021-2026) & (W Units) Table 21. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2027-2032) & (W Units) Table 22. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2021-2026) Table 23. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2027-2032) Table 24. Global Gonadotropin-releasing Hormone Antagonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Gonadotropin-releasing Hormone Antagonists Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Manufacturers (2021-2026) Table 28. Global Gonadotropin-releasing Hormone Antagonists Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Gonadotropin-releasing Hormone Antagonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Gonadotropin-releasing Hormone Antagonists Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Gonadotropin-releasing Hormone Antagonists Manufacturers, Product Type & Application Table 32. Global Gonadotropin-releasing Hormone Antagonists Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Gonadotropin-releasing Hormone Antagonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2021-2026) Table 39. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2027-2032) Table 40. Global Gonadotropin-releasing Hormone Antagonists Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 41. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2026) & (W Units) Table 42. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2027-2032) & (W Units) Table 43. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2021-2026) Table 44. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2027-2032) Table 45. Global Gonadotropin-releasing Hormone Antagonists Price by Type (2021-2026) & (US$/Unit) Table 46. Global Gonadotropin-releasing Hormone Antagonists Price by Type (2027-2032) & (US$/Unit) Table 47. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2021-2026) Table 51. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2027-2032) Table 52. Global Gonadotropin-releasing Hormone Antagonists Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 53. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2026) & (W Units) Table 54. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2027-2032) & (W Units) Table 55. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2021-2026) Table 56. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2027-2032) Table 57. Global Gonadotropin-releasing Hormone Antagonists Price by Application (2021-2026) & (US$/Unit) Table 58. Global Gonadotropin-releasing Hormone Antagonists Price by Application (2027-2032) & (US$/Unit) Table 59. Ferring Pharmaceuticals Company Information Table 60. Ferring Pharmaceuticals Business Overview Table 61. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 63. Ferring Pharmaceuticals Recent Development Table 64. Kissei Company Information Table 65. Kissei Business Overview Table 66. Kissei Gonadotropin-releasing Hormone Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Kissei Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 68. Kissei Recent Development Table 69. Myovant Sciences Company Information Table 70. Myovant Sciences Business Overview Table 71. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 73. Myovant Sciences Recent Development Table 74. Veru Inc Company Information Table 75. Veru Inc Business Overview Table 76. Veru Inc Gonadotropin-releasing Hormone Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Veru Inc Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 78. Veru Inc Recent Development Table 79. AstraZeneca Company Information Table 80. AstraZeneca Business Overview Table 81. AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 83. AstraZeneca Recent Development Table 84. AbbVie Company Information Table 85. AbbVie Business Overview Table 86. AbbVie Gonadotropin-releasing Hormone Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. AbbVie Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 88. AbbVie Recent Development Table 89. Astellas Company Information Table 90. Astellas Business Overview Table 91. Astellas Gonadotropin-releasing Hormone Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Astellas Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 93. Astellas Recent Development Table 94. Jiangsu Hengrui Medicine Co Company Information Table 95. Jiangsu Hengrui Medicine Co Business Overview Table 96. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 98. Jiangsu Hengrui Medicine Co Recent Development Table 99. Takeda Company Information Table 100. Takeda Business Overview Table 101. Takeda Gonadotropin-releasing Hormone Antagonists Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Takeda Gonadotropin-releasing Hormone Antagonists Product Portfolio Table 103. Takeda Recent Development Table 104. North America Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Gonadotropin-releasing Hormone Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2026) & (W Units) Table 107. North America Gonadotropin-releasing Hormone Antagonists Sales by Type (2027-2032) & (W Units) Table 108. North America Gonadotropin-releasing Hormone Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 109. North America Gonadotropin-releasing Hormone Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 110. North America Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Gonadotropin-releasing Hormone Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2026) & (W Units) Table 113. North America Gonadotropin-releasing Hormone Antagonists Sales by Application (2027-2032) & (W Units) Table 114. North America Gonadotropin-releasing Hormone Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 115. North America Gonadotropin-releasing Hormone Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 116. North America Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. North America Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 120. North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2026) & (W Units) Table 121. North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2027-2032) & (W Units) Table 122. North America Gonadotropin-releasing Hormone Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 123. North America Gonadotropin-releasing Hormone Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 124. United States Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 125. Canada Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 126. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2026) & (W Units) Table 129. Europe Gonadotropin-releasing Hormone Antagonists Sales by Type (2027-2032) & (W Units) Table 130. Europe Gonadotropin-releasing Hormone Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 131. Europe Gonadotropin-releasing Hormone Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 132. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2026) & (W Units) Table 135. Europe Gonadotropin-releasing Hormone Antagonists Sales by Application (2027-2032) & (W Units) Table 136. Europe Gonadotropin-releasing Hormone Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 137. Europe Gonadotropin-releasing Hormone Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 138. Europe Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 142. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2026) & (W Units) Table 143. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2027-2032) & (W Units) Table 144. Europe Gonadotropin-releasing Hormone Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 145. Europe Gonadotropin-releasing Hormone Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 146. Germany Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 147. France Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 148. U.K. Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 149. Italy Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 151. China Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 152. China Gonadotropin-releasing Hormone Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 153. China Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2026) & (W Units) Table 154. China Gonadotropin-releasing Hormone Antagonists Sales by Type (2027-2032) & (W Units) Table 155. China Gonadotropin-releasing Hormone Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 156. China Gonadotropin-releasing Hormone Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 157. China Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 158. China Gonadotropin-releasing Hormone Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 159. China Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2026) & (W Units) Table 160. China Gonadotropin-releasing Hormone Antagonists Sales by Application (2027-2032) & (W Units) Table 161. China Gonadotropin-releasing Hormone Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 162. China Gonadotropin-releasing Hormone Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 163. Asia Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Gonadotropin-releasing Hormone Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2026) & (W Units) Table 166. Asia Gonadotropin-releasing Hormone Antagonists Sales by Type (2027-2032) & (W Units) Table 167. Asia Gonadotropin-releasing Hormone Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 168. Asia Gonadotropin-releasing Hormone Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 169. Asia Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Gonadotropin-releasing Hormone Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2026) & (W Units) Table 172. Asia Gonadotropin-releasing Hormone Antagonists Sales by Application (2027-2032) & (W Units) Table 173. Asia Gonadotropin-releasing Hormone Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 174. Asia Gonadotropin-releasing Hormone Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 175. Asia Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Gonadotropin-releasing Hormone Antagonists Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 179. Asia Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2026) & (W Units) Table 180. Asia Gonadotropin-releasing Hormone Antagonists Sales by Country (2027-2032) & (W Units) Table 181. Asia Gonadotropin-releasing Hormone Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 182. Asia Gonadotropin-releasing Hormone Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Japan Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 184. South Korea Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 185. India Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 186. Australia Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 187. China Taiwan Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Gonadotropin-releasing Hormone Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2026) & (W Units) Table 192. SAMEA Gonadotropin-releasing Hormone Antagonists Sales by Type (2027-2032) & (W Units) Table 193. SAMEA Gonadotropin-releasing Hormone Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 194. SAMEA Gonadotropin-releasing Hormone Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 195. SAMEA Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Gonadotropin-releasing Hormone Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2026) & (W Units) Table 198. SAMEA Gonadotropin-releasing Hormone Antagonists Sales by Application (2027-2032) & (W Units) Table 199. SAMEA Gonadotropin-releasing Hormone Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 200. SAMEA Gonadotropin-releasing Hormone Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 201. SAMEA Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Gonadotropin-releasing Hormone Antagonists Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 205. SAMEA Gonadotropin-releasing Hormone Antagonists Sales by Country (2021-2026) & (W Units) Table 206. SAMEA Gonadotropin-releasing Hormone Antagonists Sales by Country (2027-2032) & (W Units) Table 207. SAMEA Gonadotropin-releasing Hormone Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 208. SAMEA Gonadotropin-releasing Hormone Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 209. Brazil Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 210. Argentina Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 211. Chile Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 212. Colombia Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 213. Peru Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 215. Israel Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 216. UAE Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 217. Turkey Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 218. Iran Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 219. Egypt Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Gonadotropin-releasing Hormone Antagonists Distributors List Table 223. Gonadotropin-releasing Hormone Antagonists Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Gonadotropin-releasing Hormone Antagonists Image Figure 2. Global Gonadotropin-releasing Hormone Antagonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gonadotropin-releasing Hormone Antagonists Market Size Share 2021 VS 2025 VS 2032 Figure 4. Peptides Image Figure 5. Small Molecules Image Figure 6. Global Gonadotropin-releasing Hormone Antagonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Gonadotropin-releasing Hormone Antagonists Market Size Share 2021 VS 2025 VS 2032 Figure 8. Endometriosis Image Figure 9. Uterine Fibroids Image Figure 10. Prostate Cancer Image Figure 11. Female Infertility Image Figure 12. Others Image Figure 13. Global Gonadotropin-releasing Hormone Antagonists Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gonadotropin-releasing Hormone Antagonists Revenue (2021-2032) & (US$ Million) Figure 15. Global Gonadotropin-releasing Hormone Antagonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2021-2032) Figure 18. Global Gonadotropin-releasing Hormone Antagonists Sales (2021-2032) & (W Units) Figure 19. Global Gonadotropin-releasing Hormone Antagonists Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 20. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Gonadotropin-releasing Hormone Antagonists Sales YoY (2021-2032) & (W Units) Figure 22. Europe Gonadotropin-releasing Hormone Antagonists Sales YoY (2021-2032) & (W Units) Figure 23. China Gonadotropin-releasing Hormone Antagonists Sales YoY (2021-2032) & (W Units) Figure 24. Asia (Excluding China) Gonadotropin-releasing Hormone Antagonists Sales YoY (2021-2032) & (W Units) Figure 25. South America, Middle East and Africa Gonadotropin-releasing Hormone Antagonists Sales YoY (2021-2032) & (W Units) Figure 26. Global Gonadotropin-releasing Hormone Antagonists Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Gonadotropin-releasing Hormone Antagonists Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2021-2032) Figure 32. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 33. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2021-2032) Figure 35. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2021-2032) Figure 38. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 39. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2021-2032) Figure 41. North America Gonadotropin-releasing Hormone Antagonists Revenue Share by Type (2021-2032) Figure 42. North America Gonadotropin-releasing Hormone Antagonists Sales Share by Type (2021-2032) Figure 43. North America Gonadotropin-releasing Hormone Antagonists Revenue Share by Application (2021-2032) Figure 44. North America Gonadotropin-releasing Hormone Antagonists Sales Share by Application (2021-2032) Figure 45. North America Gonadotropin-releasing Hormone Antagonists Revenue Share by Country (2021-2032) Figure 46. North America Gonadotropin-releasing Hormone Antagonists Sales Share by Country (2021-2032) Figure 47. Europe Gonadotropin-releasing Hormone Antagonists Revenue Share by Type (2021-2032) Figure 48. Europe Gonadotropin-releasing Hormone Antagonists Sales Share by Type (2021-2032) Figure 49. Europe Gonadotropin-releasing Hormone Antagonists Revenue Share by Application (2021-2032) Figure 50. Europe Gonadotropin-releasing Hormone Antagonists Sales Share by Application (2021-2032) Figure 51. Europe Gonadotropin-releasing Hormone Antagonists Revenue Share by Country (2021-2032) Figure 52. Europe Gonadotropin-releasing Hormone Antagonists Sales Share by Country (2021-2032) Figure 53. China Gonadotropin-releasing Hormone Antagonists Revenue Share by Type (2021-2032) Figure 54. China Gonadotropin-releasing Hormone Antagonists Sales Share by Type (2021-2032) Figure 55. China Gonadotropin-releasing Hormone Antagonists Revenue Share by Application (2021-2032) Figure 56. China Gonadotropin-releasing Hormone Antagonists Sales Share by Application (2021-2032) Figure 57. Asia Gonadotropin-releasing Hormone Antagonists Revenue Share by Type (2021-2032) Figure 58. Asia Gonadotropin-releasing Hormone Antagonists Sales Share by Type (2021-2032) Figure 59. Asia Gonadotropin-releasing Hormone Antagonists Revenue Share by Application (2021-2032) Figure 60. Asia Gonadotropin-releasing Hormone Antagonists Sales Share by Application (2021-2032) Figure 61. Asia Gonadotropin-releasing Hormone Antagonists Revenue Share by Country (2021-2032) Figure 62. Asia Gonadotropin-releasing Hormone Antagonists Sales Share by Country (2021-2032) Figure 63. SAMEA Gonadotropin-releasing Hormone Antagonists Revenue Share by Type (2021-2032) Figure 64. SAMEA Gonadotropin-releasing Hormone Antagonists Sales Share by Type (2021-2032) Figure 65. SAMEA Gonadotropin-releasing Hormone Antagonists Revenue Share by Application (2021-2032) Figure 66. SAMEA Gonadotropin-releasing Hormone Antagonists Sales Share by Application (2021-2032) Figure 67. SAMEA Gonadotropin-releasing Hormone Antagonists Revenue Share by Country (2021-2032) Figure 68. SAMEA Gonadotropin-releasing Hormone Antagonists Sales Share by Country (2021-2032) Figure 69. Gonadotropin-releasing Hormone Antagonists Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Gonadotropin-releasing Hormone Antagonists Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Peptides
  • Small Molecules
Applications
  • Endometriosis
  • Uterine Fibroids
  • Prostate Cancer
  • Female Infertility
  • Others
Companies covered
  • Ferring Pharmaceuticals
  • Kissei
  • Myovant Sciences
  • Veru Inc
  • AstraZeneca
  • AbbVie
  • Astellas
  • Jiangsu Hengrui Medicine Co
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gonadotropin-releasing Hormone Antagonists Market by Type
  3. 1.2.1 Global Gonadotropin-releasing Hormone Antagonists Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Peptides
  5. 1.2.3 Small Molecules
  6. 1.3 Gonadotropin-releasing Hormone Antagonists Market by Application
  7. 1.3.1 Global Gonadotropin-releasing Hormone Antagonists Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Endometriosis
  9. 1.3.3 Uterine Fibroids
  10. 1.3.4 Prostate Cancer
  11. 1.3.5 Female Infertility
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Gonadotropin-releasing Hormone Antagonists Market Dynamics
  1. 2.1 Gonadotropin-releasing Hormone Antagonists Industry Trends
  2. 2.2 Gonadotropin-releasing Hormone Antagonists Industry Drivers
  3. 2.3 Gonadotropin-releasing Hormone Antagonists Industry Opportunities and Challenges
  4. 2.4 Gonadotropin-releasing Hormone Antagonists Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gonadotropin-releasing Hormone Antagonists Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region
  3. 3.2.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2021-2026)
  5. 3.2.3 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2027-2032)
  6. 3.2.4 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gonadotropin-releasing Hormone Antagonists Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gonadotropin-releasing Hormone Antagonists Sales by Region
  9. 3.4.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2021-2026)
  11. 3.4.3 Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2027-2032)
  12. 3.4.4 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Manufacturers
  2. 4.1.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gonadotropin-releasing Hormone Antagonists Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Manufacturers
  6. 4.2.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gonadotropin-releasing Hormone Antagonists Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gonadotropin-releasing Hormone Antagonists Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gonadotropin-releasing Hormone Antagonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gonadotropin-releasing Hormone Antagonists Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gonadotropin-releasing Hormone Antagonists Manufacturers, Product Type & Application
  13. 4.7 Global Gonadotropin-releasing Hormone Antagonists Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gonadotropin-releasing Hormone Antagonists Market CR5 and HHI
  16. 4.8.2 2025 Gonadotropin-releasing Hormone Antagonists Tier 1, Tier 2, and Tier 3
5 Gonadotropin-releasing Hormone Antagonists Market by Type
  1. 5.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type
  2. 5.1.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Type
  6. 5.2.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gonadotropin-releasing Hormone Antagonists Price by Type
6 Gonadotropin-releasing Hormone Antagonists Market by Application
  1. 6.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application
  2. 6.1.1 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Application
  6. 6.2.1 Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gonadotropin-releasing Hormone Antagonists Price by Application
7 Company Profiles
  1. 7.1 Ferring Pharmaceuticals
  2. 7.1.1 Ferring Pharmaceuticals Company Information
  3. 7.1.2 Ferring Pharmaceuticals Business Overview
  4. 7.1.3 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product Portfolio
  6. 7.1.5 Ferring Pharmaceuticals Recent Developments
  7. 7.2 Kissei
  8. 7.2.1 Kissei Company Information
  9. 7.2.2 Kissei Business Overview
  10. 7.2.3 Kissei Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Kissei Gonadotropin-releasing Hormone Antagonists Product Portfolio
  12. 7.2.5 Kissei Recent Developments
  13. 7.3 Myovant Sciences
  14. 7.3.1 Myovant Sciences Company Information
  15. 7.3.2 Myovant Sciences Business Overview
  16. 7.3.3 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product Portfolio
  18. 7.3.5 Myovant Sciences Recent Developments
  19. 7.4 Veru Inc
  20. 7.4.1 Veru Inc Company Information
  21. 7.4.2 Veru Inc Business Overview
  22. 7.4.3 Veru Inc Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Veru Inc Gonadotropin-releasing Hormone Antagonists Product Portfolio
  24. 7.4.5 Veru Inc Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca Gonadotropin-releasing Hormone Antagonists Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 AbbVie
  32. 7.6.1 AbbVie Company Information
  33. 7.6.2 AbbVie Business Overview
  34. 7.6.3 AbbVie Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AbbVie Gonadotropin-releasing Hormone Antagonists Product Portfolio
  36. 7.6.5 AbbVie Recent Developments
  37. 7.7 Astellas
  38. 7.7.1 Astellas Company Information
  39. 7.7.2 Astellas Business Overview
  40. 7.7.3 Astellas Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Astellas Gonadotropin-releasing Hormone Antagonists Product Portfolio
  42. 7.7.5 Astellas Recent Developments
  43. 7.8 Jiangsu Hengrui Medicine Co
  44. 7.8.1 Jiangsu Hengrui Medicine Co Company Information
  45. 7.8.2 Jiangsu Hengrui Medicine Co Business Overview
  46. 7.8.3 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product Portfolio
  48. 7.8.5 Jiangsu Hengrui Medicine Co Recent Developments
  49. 7.9 Takeda
  50. 7.9.1 Takeda Company Information
  51. 7.9.2 Takeda Business Overview
  52. 7.9.3 Takeda Gonadotropin-releasing Hormone Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Takeda Gonadotropin-releasing Hormone Antagonists Product Portfolio
  54. 7.9.5 Takeda Recent Developments
8 North America
  1. 8.1 North America Gonadotropin-releasing Hormone Antagonists Market Size by Type
  2. 8.1.1 North America Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2032)
  3. 8.1.2 North America Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2032)
  4. 8.1.3 North America Gonadotropin-releasing Hormone Antagonists Price by Type (2021-2032)
  5. 8.2 North America Gonadotropin-releasing Hormone Antagonists Market Size by Application
  6. 8.2.1 North America Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2032)
  7. 8.2.2 North America Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2032)
  8. 8.2.3 North America Gonadotropin-releasing Hormone Antagonists Price by Application (2021-2032)
  9. 8.3 North America Gonadotropin-releasing Hormone Antagonists Market Size by Country
  10. 8.3.1 North America Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gonadotropin-releasing Hormone Antagonists Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Gonadotropin-releasing Hormone Antagonists Market Size by Type
  2. 9.1.1 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2032)
  4. 9.1.3 Europe Gonadotropin-releasing Hormone Antagonists Price by Type (2021-2032)
  5. 9.2 Europe Gonadotropin-releasing Hormone Antagonists Market Size by Application
  6. 9.2.1 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2032)
  8. 9.2.3 Europe Gonadotropin-releasing Hormone Antagonists Price by Application (2021-2032)
  9. 9.3 Europe Gonadotropin-releasing Hormone Antagonists Market Size by Country
  10. 9.3.1 Europe Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gonadotropin-releasing Hormone Antagonists Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Gonadotropin-releasing Hormone Antagonists Market Size by Type
  2. 10.1.1 China Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2032)
  3. 10.1.2 China Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2032)
  4. 10.1.3 China Gonadotropin-releasing Hormone Antagonists Price by Type (2021-2032)
  5. 10.2 China Gonadotropin-releasing Hormone Antagonists Market Size by Application
  6. 10.2.1 China Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2032)
  7. 10.2.2 China Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2032)
  8. 10.2.3 China Gonadotropin-releasing Hormone Antagonists Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gonadotropin-releasing Hormone Antagonists Market Size by Type
  2. 11.1.1 Asia Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2032)
  4. 11.1.3 Asia Gonadotropin-releasing Hormone Antagonists Price by Type (2021-2032)
  5. 11.2 Asia Gonadotropin-releasing Hormone Antagonists Market Size by Application
  6. 11.2.1 Asia Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2032)
  8. 11.2.3 Asia Gonadotropin-releasing Hormone Antagonists Price by Application (2021-2032)
  9. 11.3 Asia Gonadotropin-releasing Hormone Antagonists Market Size by Country
  10. 11.3.1 Asia Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gonadotropin-releasing Hormone Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gonadotropin-releasing Hormone Antagonists Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gonadotropin-releasing Hormone Antagonists Market Size by Type
  2. 12.1.1 SAMEA Gonadotropin-releasing Hormone Antagonists Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gonadotropin-releasing Hormone Antagonists Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gonadotropin-releasing Hormone Antagonists Price by Type (2021-2032)
  5. 12.2 SAMEA Gonadotropin-releasing Hormone Antagonists Market Size by Application
  6. 12.2.1 SAMEA Gonadotropin-releasing Hormone Antagonists Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gonadotropin-releasing Hormone Antagonists Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gonadotropin-releasing Hormone Antagonists Price by Application (2021-2032)
  9. 12.3 SAMEA Gonadotropin-releasing Hormone Antagonists Market Size by Country
  10. 12.3.1 SAMEA Gonadotropin-releasing Hormone Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gonadotropin-releasing Hormone Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gonadotropin-releasing Hormone Antagonists Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gonadotropin-releasing Hormone Antagonists Value Chain Analysis
  2. 13.1.1 Gonadotropin-releasing Hormone Antagonists Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gonadotropin-releasing Hormone Antagonists Production Mode & Process
  6. 13.2 Gonadotropin-releasing Hormone Antagonists Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gonadotropin-releasing Hormone Antagonists Distributors
  9. 13.2.3 Gonadotropin-releasing Hormone Antagonists Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst